• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于儿童期发病的1型糖尿病队列中微量白蛋白尿及进展为大量白蛋白尿风险的前瞻性观察研究。

Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

作者信息

Amin Rakesh, Widmer Barry, Prevost A Toby, Schwarze Phillip, Cooper Jason, Edge Julie, Marcovecchio Loredana, Neil Andrew, Dalton R Neil, Dunger David B

机构信息

University Department of Paediatrics, Addenbrooke's Hospital, Cambridge CB2 0QQ.

出版信息

BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.

DOI:10.1136/bmj.39478.378241.BE
PMID:18349042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2276285/
Abstract

OBJECTIVES

To describe independent predictors for the development of microalbuminuria and progression to macroalbuminuria in those with childhood onset type 1 diabetes.

DESIGN

Prospective observational study with follow-up for 9.8 (SD 3.8) years.

SETTING

Oxford regional prospective study.

PARTICIPANTS

527 participants with a diagnosis of type 1 diabetes at mean age 8.8 (SD 4.0) years.

MAIN OUTCOME MEASURES

Annual measurement of glycated haemoglobin (HbA1c) and assessment of urinary albumin:creatinine ratio.

RESULTS

Cumulative prevalence of microalbuminuria was 25.7% (95% confidence interval 21.3% to 30.1%) after 10 years of diabetes and 50.7% (40.5% to 60.9%) after 19 years of diabetes and 5182 patient years of follow-up. The only modifiable adjusted predictor for microalbuminuria was high HbA1c concentrations (hazard ratio per 1% rise in HbA1c 1.39, 1.27 to 1.52). Blood pressure and history of smoking were not predictors. Microalbuminuria was persistent in 48% of patients. Cumulative prevalence of progression from microalbuminuria to macroalbuminuria was 13.9% (12.9% to 14.9%); progression occurred at a mean age of 18.5 (5.8) years. Although the sample size was small, modifiable predictors of macroalbuminuria were higher HbA(1c) levels and both persistent and intermittent microalbuminuria (hazard ratios 1.42 (1.22 to 1.78), 27.72 (7.99 to 96.12), and 8.76 (2.44 to 31.44), respectively).

CONCLUSION

In childhood onset type 1 diabetes, the only modifiable predictors were poor glycaemic control for the development of microalbuminuria and poor control and microalbuminuria (both persistent and intermittent) for progression to macroalbuminuria. Risk for macroalbuminuria is similar to that observed in cohorts with adult onset disease but as it occurs in young adult life early intervention in normotensive adolescents might be needed to improve prognosis.

摘要

目的

描述儿童期发病的1型糖尿病患者发生微量白蛋白尿及进展为大量白蛋白尿的独立预测因素。

设计

前瞻性观察性研究,随访9.8(标准差3.8)年。

地点

牛津地区前瞻性研究。

参与者

527例平均年龄8.8(标准差4.0)岁时被诊断为1型糖尿病的患者。

主要观察指标

每年测定糖化血红蛋白(HbA1c)并评估尿白蛋白:肌酐比值。

结果

糖尿病病程10年后微量白蛋白尿的累积患病率为25.7%(95%置信区间21.3%至30.1%),糖尿病病程19年后及5182患者年随访后为50.7%(40.5%至60.9%)。微量白蛋白尿唯一可改变的校正预测因素是高HbA1c浓度(HbA1c每升高1%的风险比为1.39,1.27至1.52)。血压和吸烟史不是预测因素。48%的患者微量白蛋白尿持续存在。从微量白蛋白尿进展为大量白蛋白尿的累积患病率为13.9%(12.9%至14.9%);进展发生的平均年龄为18.5(5.8)岁。尽管样本量较小,但大量白蛋白尿的可改变预测因素是较高的HbA1c水平以及持续性和间歇性微量白蛋白尿(风险比分别为1.42(1.22至1.78)、27.72(7.99至96.12)和8.76(2.44至31.44))。

结论

在儿童期发病的1型糖尿病中,唯一可改变的预测因素是血糖控制不佳导致微量白蛋白尿的发生,以及控制不佳和微量白蛋白尿(持续性和间歇性)导致进展为大量白蛋白尿。大量白蛋白尿的风险与成年发病队列中观察到的风险相似,但由于其发生在年轻成年期,可能需要对血压正常的青少年进行早期干预以改善预后。

相似文献

1
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.一项关于儿童期发病的1型糖尿病队列中微量白蛋白尿及进展为大量白蛋白尿风险的前瞻性观察研究。
BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.
2
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.1型糖尿病患者微量白蛋白尿和大量白蛋白尿发生的预测因素:队列起始研究
BMJ. 2004 May 8;328(7448):1105. doi: 10.1136/bmj.38070.450891.FE. Epub 2004 Apr 19.
3
Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.1型糖尿病患者发生早期和显性糖尿病肾病的危险因素:一项为期10年的前瞻性观察研究。
Diabetes Care. 2002 May;25(5):859-64. doi: 10.2337/diacare.25.5.859.
4
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.1型糖尿病合并微量白蛋白尿患者的长期肾脏转归:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学队列分析
Arch Intern Med. 2011 Mar 14;171(5):412-20. doi: 10.1001/archinternmed.2011.16.
5
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).2型糖尿病肾病的发生与进展:英国前瞻性糖尿病研究(UKPDS 64)
Kidney Int. 2003 Jan;63(1):225-32. doi: 10.1046/j.1523-1755.2003.00712.x.
6
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
7
Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.年轻人 1 型糖尿病中微量白蛋白尿的发生:年龄和糖尿病病程的重要性。
Diabet Med. 2010 May;27(5):532-7. doi: 10.1111/j.1464-5491.2010.02983.x.
8
HbA1C Variability Is Strongly Associated with Development of Macroalbuminuria in Normal or Microalbuminuria in Patients with Type 2 Diabetes Mellitus: A Six-Year Follow-Up Study.糖化血红蛋白变异性与 2 型糖尿病患者正常白蛋白尿或微量白蛋白尿进展到大白蛋白尿密切相关:一项为期六年的随访研究。
Biomed Res Int. 2020 Jan 25;2020:7462158. doi: 10.1155/2020/7462158. eCollection 2020.
9
[Prevalence and determinants of microalbuminuria and macroalbuminuria in children and young adults with type 1 diabetes in Kinshasa].[金沙萨1型糖尿病儿童和青年微量白蛋白尿和大量白蛋白尿的患病率及决定因素]
Nephrol Ther. 2010 Feb;6(1):40-6. doi: 10.1016/j.nephro.2009.08.001. Epub 2009 Oct 22.
10
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.恩格列净对 2 型糖尿病合并已确诊心血管疾病患者的尿白蛋白与肌酐比值的影响:来自 EMPA-REG OUTCOME 随机、安慰剂对照试验的探索性分析。
Lancet Diabetes Endocrinol. 2017 Aug;5(8):610-621. doi: 10.1016/S2213-8587(17)30182-1. Epub 2017 Jun 27.

引用本文的文献

1
Association between urinary albumin-to-creatinine ratio within the normal range and continuous glucose monitoring-derived metrics in children and adolescents with type 1 diabetes.1型糖尿病儿童及青少年正常范围内尿白蛋白与肌酐比值与持续葡萄糖监测指标之间的关联
Diabetol Metab Syndr. 2025 May 26;17(1):173. doi: 10.1186/s13098-025-01749-x.
2
Role of Renal Resistive Index as an Early Marker of Diabetic Nephropathy in Children With Type 1 Diabetes Mellitus.肾阻力指数作为1型糖尿病儿童糖尿病肾病早期标志物的作用
Cureus. 2025 Apr 13;17(4):e82202. doi: 10.7759/cureus.82202. eCollection 2025 Apr.
3
Related factors for kidney disease and high chronic kidney disease progression risk in adult-onset type 1 diabetes mellitus patients from China: a multi-center cross-sectional study.中国成年起病1型糖尿病患者肾病及慢性肾病高进展风险的相关因素:一项多中心横断面研究
Ren Fail. 2025 Dec;47(1):2483389. doi: 10.1080/0886022X.2025.2483389. Epub 2025 Mar 26.
4
INCREASED RENAL RESISTIVE INDEX AS A MARKER OF EARLY STAGE OF DIABETIC NEPHROPATHY IN NORMOALBUMINURIC CHILDREN WITH TYPE 1 DIABETES MELLITUS.肾阻力指数升高作为1型糖尿病正常白蛋白尿儿童糖尿病肾病早期阶段的标志物
Acta Clin Croat. 2024 Apr;63(1):36-44. doi: 10.20471/acc.2024.63.01.5.
5
Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.血清血管生成素-2:1 型糖尿病儿童和青少年早期糖尿病肾病有前景的生物标志物。
Eur J Pediatr. 2024 Sep;183(9):3853-3862. doi: 10.1007/s00431-024-05637-w. Epub 2024 Jun 17.
6
Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes.1 型糖尿病短期严重高血糖时的一过性白蛋白尿。
J Diabetes Complications. 2024 Jun;38(6):108762. doi: 10.1016/j.jdiacomp.2024.108762. Epub 2024 Apr 29.
7
U-shaped relationship between fasting blood glucose and urinary albumin-to-creatinine ratio in the general United States population.在美国普通人群中,空腹血糖与尿白蛋白与肌酐比值之间呈 U 型关系。
Front Endocrinol (Lausanne). 2024 Mar 15;15:1334949. doi: 10.3389/fendo.2024.1334949. eCollection 2024.
8
Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk.青春期后至 30 岁之间发病的 1 型糖尿病与糖尿病肾病风险增加相关。
Sci Rep. 2024 Feb 13;14(1):3611. doi: 10.1038/s41598-024-54137-2.
9
Progression and regression of kidney disease in type 1 diabetes.1型糖尿病肾病的进展与逆转
Front Nephrol. 2023 Dec 14;3:1282818. doi: 10.3389/fneph.2023.1282818. eCollection 2023.
10
Development of a High-Accuracy, Low-Cost, and Portable Fluorometer with Smartphone Application for the Detection of Urinary Albumin towards the Early Screening of Chronic Kidney and Renal Diseases.开发一种高精度、低成本、便携式的荧光计,结合智能手机应用程序,用于检测尿液白蛋白,以实现慢性肾病和肾脏疾病的早期筛查。
Biosensors (Basel). 2023 Sep 8;13(9):876. doi: 10.3390/bios13090876.

本文引用的文献

1
The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study.年轻1型糖尿病患者微量白蛋白尿与肾小球滤过率的关系:牛津地区前瞻性研究。
Kidney Int. 2005 Oct;68(4):1740-9. doi: 10.1111/j.1523-1755.2005.00590.x.
2
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.1型糖尿病非选择性人群中严重视网膜病变发病率的下降及肾病的持续减少——林雪平糖尿病并发症研究
Diabetologia. 2004 Jul;47(7):1266-1272. doi: 10.1007/s00125-004-1431-6. Epub 2004 Jul 2.
3
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.1型糖尿病患者微量白蛋白尿和大量白蛋白尿发生的预测因素:队列起始研究
BMJ. 2004 May 8;328(7448):1105. doi: 10.1136/bmj.38070.450891.FE. Epub 2004 Apr 19.
4
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.1型糖尿病强化治疗对糖尿病肾病发生及进展的持续影响:糖尿病干预与并发症流行病学(EDIC)研究
JAMA. 2003 Oct 22;290(16):2159-67. doi: 10.1001/jama.290.16.2159.
5
Regression of microalbuminuria in type 1 diabetes.1型糖尿病中微量白蛋白尿的消退
N Engl J Med. 2003 Jun 5;348(23):2285-93. doi: 10.1056/NEJMoa021835.
6
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study.与正常白蛋白尿对照受试者相比,1型糖尿病患者在青春期出现微量白蛋白尿时胰岛素样生长因子-I水平较低且睾酮水平升高:牛津地区前瞻性研究。
Diabetes Care. 2003 May;26(5):1456-61. doi: 10.2337/diacare.26.5.1456.
7
Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group.一项针对1型糖尿病青少年患者的为期3年的国际调查中的胰岛素注射方案与代谢控制:赫维多研究组的结果
Eur J Pediatr. 2003 Jan;162(1):22-9. doi: 10.1007/s00431-002-1037-2. Epub 2002 Nov 26.
8
Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study.从青少年到青年期糖尿病的临床和心理病程:一项纵向队列研究
Diabetes Care. 2001 Sep;24(9):1536-40. doi: 10.2337/diacare.24.9.1536.
9
Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes.在1型糖尿病确诊后的最初几年,肾病风险可在微量白蛋白尿出现之前被检测到。
Diabetes Care. 2000 Dec;23(12):1811-5. doi: 10.2337/diacare.23.12.1811.
10
A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.一项针对1型糖尿病青少年血糖控制情况的全国性队列研究,为期6年。视网膜病变、肾病和神经病变发生的风险标志物。丹麦儿童糖尿病研究小组
J Diabetes Complications. 2000 Nov-Dec;14(6):295-300. doi: 10.1016/s1056-8727(00)00078-7.